![Sujay Kango](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sujay Kango
Vorstandsvorsitzender bei Tmunity Therapeutics, Inc.
Vermögen: - $ am 31.01.2024
Aktive Positionen von Sujay Kango
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tmunity Therapeutics, Inc.
![]() Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Vorstandsvorsitzender | - | - |
Präsident | - | - |
Karriereverlauf von Sujay Kango
Ehemalige bekannte Positionen von Sujay Kango
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEI PHARMA, INC. | Direktor/Vorstandsmitglied | 22.11.2021 | 31.10.2023 |
Independent Dir/Board Member | 22.11.2021 | 31.10.2023 | |
INFINITY PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 30.03.2022 | 24.07.2023 |
Independent Dir/Board Member | 30.03.2022 | 24.07.2023 | |
ABBVIE INC. | Corporate Officer/Principal | 01.01.2017 | 01.02.2018 |
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 14.04.2015 | 06.01.2017 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Vertrieb & Marketing | 01.04.2011 | 01.03.2015 |
MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2006 | 01.03.2011 |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Vertrieb & Marketing | - | - |
ACCELERON PHARMA INC. | Corporate Officer/Principal | 08.02.2018 | - |
░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Sujay Kango
McNeese State University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 11 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Sales & Marketing | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
ABBVIE INC. | Health Technology |
MEI PHARMA, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Cancer Care, Inc.
![]() Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Health Services |
Acceleron Pharma, Inc.
![]() Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Tmunity Therapeutics, Inc.
![]() Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Börse
- Insiders
- Sujay Kango
- Erfahrung